Mobile

Clinical Study of the safety and efficacy of Bimotoprost 0.03%/Timolol 0.5% Preservative-free Ophthalmic Solution compared with GANFORT®(Bimotoprost 0.03%/Timolol 0.5% Ophthalmic Solution) once daily ...

Mise à jour : Il y a 4 ans
Référence : EUCTR2010-021507-24

Clinical Study of the safety and efficacy of Bimotoprost 0.03%/Timolol 0.5% Preservative-free Ophthalmic Solution compared with GANFORT®(Bimotoprost 0.03%/Timolol 0.5% Ophthalmic Solution) once daily for 12 weeks in Patients with Glaucoma or Ocular Hypertension

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To compare the efficacy and safety of bimatoprost 0.03%/ timolol 0.5% PF ophthalmic solution with GANFORT once-daily use for 12 weeks in patients with glaucoma or ocular hypertension (OHT). To show that bimatoprost 0.03%/timolol 0.5% PF ophthalmic solution has an acceptable safety profile.

Critère d'inclusion

  • Glaucoma or ocular hypertension

Liens